Relationship of obesity to recanalization after hyperacute recombinant tissue-plasminogen activator infusion therapy in patients with middle cerebral artery occlusion

Journal of Stroke and Cerebrovascular Diseases

Volumn 21, Issue 3, 2012, Pages 161-164

  Deguchi, Ichiro ^a   Ohe, Yasuko ^a   Fukuoka, Takuya ^a   Dembo, Tomohisa ^a   Nagoya, Harumitsu ^a   Kato, Yuji ^a   Maruyama, Hajime ^a   Horiuchi, Yohsuke ^a   Tanahashi, Norio ^a  

^a SAITAMA MEDICAL UNIVERSITY INTERNATIONAL MEDICAL CENTER   (Japan)

Author keywords

middle cerebral occlusion recanalization; Obesity; recombinant tissue plasminogen activator infusion therapy

Indexed keywords

ALTEPLASE;

AGED; ARTICLE; BODY MASS; BRAIN INFARCTION; CLINICAL ARTICLE; DIFFUSION WEIGHTED IMAGING; DRUG INFUSION; FEMALE; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; OBESITY; PRIORITY JOURNAL; RECANALIZATION;

AGED; AGED, 80 AND OVER; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; OBESITY; RECOMBINANT PROTEINS; RETROSPECTIVE STUDIES; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84863403773     PISSN: 10523057     EISSN: 15328511     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2011.11.003     Document Type: Article

References (16)

1. J. Nakagawara, K. Minematsu, and Y. Okada Thrombolysis with 0.6 mg/kg Intravenous Alteplase for acute ischemic stroke in routine clinical practice: The Japan post-Marketing Alteplase Registration Study (J-MARS) Stroke 41 2010 1984 1989
2. W. Hacke, G. Donnan, and C. Fieschi Association of outcome with early stroke treatment: Pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials Lancet 363 2004 768 774
3. N. Wahlgren, N. Ahmed, and A. Davalos Thrombolysis with alteplase for acute ischemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): An observational study Lancet 369 2007 275 282 (Pubitemid 46138121)
4. J.H. Rha, and J.L. Saver The impact of recanalization on ischemic stroke outcome: A meta-analysis Stroke 38 2007 967 973 (Pubitemid 46568460)
5. K. Kimura, Y. Iguchi, and S. Yamashita Atrial fibrillation as an independent predictor for no early recanalization after IV-t-PA in acute ischemic stroke J Neurol Sci 267 2008 57 61 (Pubitemid 351248907)
6. J.F. Arenillas, L. Ispierto, and M. Millan Metabolic syndrome and resistance to IV thrombolysis in middle cerebral artery ischemic stroke Neurology 71 2008 190 195
7. J.F. Arenillas, P. Sandoval, and N. Perez The metabolic syndrome is associated with a higher resistance to intravenous thrombolysis for acute ischemic stroke in women than in men Stroke 40 2009 344 349
8. E. Mori, K. Minematsu, and J. Nakagawara Effects of 0.6 mg/kg intravenous alteplase on vascular and clinical outcomes in middle cerebral artery occlusion; Japan Alteplase Clinical Trial II (J-ACT II) Stroke 41 2010 461 465
9. Japan Atherosclerosis Society Website Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Disease Available at: http://jas.umin.ac.jp 2007 Accessed November 21, 2011
10. P.A. Barber, M.D. Hill, and M. Eliasziw Imaging of the brain in acute ischemic stroke: Comparison of computed tomography and magnetic resonance diffusion-weighted imaging J Neurol Neurosurg Psychiatry 76 2005 1528 1533 (Pubitemid 41531700)
11. M. Saqqur, K. Uchino, and A.M. Demchuk Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke Stroke 38 2007 948 954 (Pubitemid 46568457)
12. M. Saqqur, C.A. Molina, and A. Salam Clinical deterioration after intravenous recombinant tissue plasminogen activator treatment: A multicenter transcranial Doppler study Stroke 38 2007 69 74 (Pubitemid 46035608)
13. R. Marco, J. Montaner, and C.A. Molina Admission fibrinolytic profile predicts clot lysis resistance in stroke patients treated with tissue plasminogen activator Thromb Haemost 91 2004 1146 1151 (Pubitemid 38821271)
14. J.G. Van der Bom, M.L. Bots, and F. Haverkate The 4G5G polymorphism in the gene for PAI-1 and the circadian oscillation of plasma PAI-1 Blood 101 2003 1841 1844 (Pubitemid 36237582)
15. T. Urano, K. Sumiyoshi, and M. Nakamura Fluctuation of tPA and PAI-1 antigen levels in plasma: Difference of their fluctuation patterns between male and female Thrombosis Res 60 1990 133 139
16. J. Diedler, N. Ahmed, and J. Glahn Is the maximum dose of 90 mg alteplase sufficient for patients with ischemic stroke weighing >100 kg? Stroke 42 2011 1615 1620